PNC Financial Services Group’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$358K Buy
23,750
+2,933
+14% +$51.2K ﹤0.01% 2034
2026
Q1
$399K Sell
20,817
-1,530
-7% -$33.2K ﹤0.01% 1846
2025
Q4
$491K Buy
22,347
+1,192
+6% +$21.5K ﹤0.01% 1676
2025
Q3
$257K Buy
21,155
+201
+1% +$2.72K ﹤0.01% 2127
2025
Q2
$391K Buy
20,954
+1,719
+9% +$34K ﹤0.01% 1736
2025
Q1
$369K Sell
19,235
-3,004
-14% -$87.9K ﹤0.01% 1744
2024
Q4
$801K Buy
22,239
+2,720
+14% +$92K ﹤0.01% 1266
2024
Q3
$828K Buy
19,519
+5,247
+37% +$222K ﹤0.01% 1251
2024
Q2
$575K Buy
14,272
+8,639
+153% +$360K ﹤0.01% 1412
2024
Q1
$199K Sell
5,633
-155
-3% -$4.15K ﹤0.01% 2170
2023
Q4
$171K Buy
5,788
+2,562
+79% +$53.1K ﹤0.01% 2260
2023
Q3
$67K Buy
3,226
+1,099
+52% +$30.2K ﹤0.01% 2799
2023
Q2
$52.2K Sell
2,127
-3,170
-60% -$102K ﹤0.01% 3034
2023
Q1
$215K Buy
5,297
+3,184
+151% +$132K ﹤0.01% 2100
2022
Q4
$95K Sell
2,113
-4,715
-69% -$213K ﹤0.01% 2592
2022
Q3
$327K Sell
6,828
-314
-4% -$17.2K ﹤0.01% 1772
2022
Q2
$422K Buy
7,142
+896
+14% +$73.6K ﹤0.01% 1636
2022
Q1
$726K Buy
6,246
+164
+3% +$19.1K ﹤0.01% 1408
2021
Q4
$916K Buy
6,082
+482
+9% +$65.1K ﹤0.01% 1338
2021
Q3
$669K Buy
5,600
+438
+8% +$48.3K ﹤0.01% 1437
2021
Q2
$504K Sell
5,162
-335
-6% -$29.9K ﹤0.01% 1597
2021
Q1
$484K Buy
5,497
+571
+12% +$53.1K ﹤0.01% 1587
2020
Q4
$472K Buy
4,926
+1,228
+33% +$127K ﹤0.01% 1514
2020
Q3
$420K Buy
3,698
+263
+8% +$27.6K ﹤0.01% 1443
2020
Q2
$341K Sell
3,435
-920
-21% -$73.4K ﹤0.01% 1604
2020
Q1
$281K Buy
4,355
+4,280
+5,707% +$300K ﹤0.01% 1621
2019
Q4
$4K Sell
75
-4,151
-98% -$256K ﹤0.01% 3701
2019
Q3
$249K Buy
4,226
+1,874
+80% +$120K ﹤0.01% 2011
2019
Q2
$152K Buy
2,352
+865
+58% +$55.8K ﹤0.01% 2324
2019
Q1
$94K Buy
1,487
+332
+29% +$17.4K ﹤0.01% 2588
2018
Q4
$44K Buy
+1,155
New +$40.8K ﹤0.01% 2944
2018
Q1
Sell
-12
Closed 4276
2017
Q4
$0 Hold
12
﹤0.01% 4243
2017
Q3
$0 Hold
12
﹤0.01% 4228
2017
Q2
$0 Hold
12
﹤0.01% 4226
2017
Q1
$0 Buy
12
+10
+500% +$219 ﹤0.01% 4208
2016
Q4
$0 Hold
2
﹤0.01% 4095
2016
Q3
$0 Sell
2
-674
-100% -$49.2K ﹤0.01% 4267
2016
Q2
$50K Sell
676
-220
-25% -$17.7K ﹤0.01% 2839
2016
Q1
$78K Sell
896
-208
-19% -$18.2K ﹤0.01% 2613
2015
Q4
$130K Hold
1,104
﹤0.01% 2318
2015
Q3
$98K Buy
1,104
+2
+0.2% +$233 ﹤0.01% 2536
2015
Q2
$120K Buy
1,102
+360
+49% +$44.8K ﹤0.01% 2529
2015
Q1
$94K Buy
742
+658
+783% +$85.6K ﹤0.01% 2730
2014
Q4
$10K Buy
+84
New +$11.6K ﹤0.01% 3378
2014
Q3
Sell
-1,040
Closed -$170K 4054
2014
Q2
$170K Buy
1,040
+247
+31% +$42K ﹤0.01% 2013
2014
Q1
$175K Buy
+793
New +$202K ﹤0.01% 1954

Other funds holding TNDM

PNC Financial Services Group's TNDM Position: Q2 2026 in Review

PNC Financial Services Group increased its Tandem Diabetes Care (TNDM) stake by 14% in Q2 2026, buying an estimated $51.2K and bringing the position to 23,750 shares worth $358K. The position accounts for ﹤0.01% of the portfolio, ranked #2034.

PNC Financial Services Group first reported a position in TNDM in Q1 2014 and has held it in 46 quarters since. The position peaked at $916K in Q4 2021. 106 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • PNC Financial Services Group held 23,750 shares of Tandem Diabetes Care worth $358K as of Q2 2026.
  • PNC Financial Services Group bought 2,933 Tandem Diabetes Care shares in Q2 2026, an estimated $51.2K.
  • Tandem Diabetes Care made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #2034 holding.
  • PNC Financial Services Group first reported a position in Tandem Diabetes Care in Q1 2014 and has held it in 46 quarters since.
  • PNC Financial Services Group's Tandem Diabetes Care position peaked at $916K in Q4 2021.
  • 106 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.